MELOXICAM
Generic: MELOXICAM
Unichem Pharmaceuticals (USA)Manufacturer
ORALRoute
MELOXICAMActive Substance
2006-12-20Original Approval
MELOXICAM is FDA application ANDA077927, sponsored by UNICHEM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2021-03-15
Meloxicam Tablets, USP 7.5 mg 100 Tablets Rx Only NDC 69097-158-07 Manufactured for: Cipla USA, Inc. 9100 S. Dadeland BlCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II2022-01-26
Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; ManufactuCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi
Top Reported Reactions
1
DRUG INEFFECTIVE
6,182 reports
2
PAIN
4,886 reports
3
FATIGUE
4,833 reports
4
ARTHRALGIA
4,413 reports
5
NAUSEA
4,028 reports
6
HEADACHE
3,527 reports
7
DIARRHOEA
3,424 reports
8
DYSPNOEA
2,829 reports
9
DIZZINESS
2,784 reports
10
OFF LABEL USE
2,751 reports